Encorium is a full service Contract Research Organization. Our extensive experience in running a range of studies in all phases, including vaccine trials and early phase (Phase I & II) development, gives us unique advantages in efficient recruitment, comprehensive management and expert trial design.

With over 20 years experience in biopharmaceuticals, Encorium employs approximately 200 staff with with operational capabilities in 30+countries, based on operations under own management with experts that are native speakers and through carefully selected Partner CRO’s. Encorium is traded publicly on the OTC list in New York (the pink sheets).

Encorium Oy Keilaranta 10 FI-02150 Espoo, Finland